Sommario

• Editorial

  • ·The State of Alzheimer’s Research and the Path Forward

    Pagina :617-619

    Howard M. Fillit, B. Vellas, Y. Hara

    

• Review

  • ·Geroscience and Alzheimer’s Disease Drug Development

    Pagina :620-632

    Jeffrey Cummings, A.M. Leisgang Osse, J. Kinney

    Riassunto Riassunto Mappa Mappa  
  • ·Translating the Biology of Aging into New Therapeutics for Alzheimer’s Disease: Senolytics

    Pagina :633-646

    M. Riessland, Miranda E. Orr

    Riassunto Riassunto Mappa Mappa  
  • ·Fibrin-Targeting Immunotherapy for Dementia

    Pagina :647-660

    A.B. Kantor, K. Akassoglou, Jeffrey B. Stavenhagen

    Riassunto Riassunto Mappa Mappa  
  • ·Opportunities for Cellular Rejuvenation in Alzheimer’s Disease: How Epigenetic Reprogramming and Chaperone-Mediated Autophagy Are Enabling Next Generation Therapeutic Approaches

    Pagina :661-668

    Sharon Rosenzweig-Lipson

    Riassunto Riassunto Mappa Mappa

• Original Research

  • ·ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer’s Disease Patients

    Pagina :669-674

    Marlies Oosthoek, A. Lili, A. Almeida, O. van Loosbroek, R. van der Geest, I. de Greef-van der Sandt, P. van Bokhoven, S.A.M. Sikkes, C.E. Teunissen, E.G.B. Vijverberg

    Riassunto Riassunto Mappa Mappa  

• Review

  • ·Modulation of Mitochondrial Function as a Therapeutic Strategy for Neurodegenerative Diseases

    Pagina :675-685

    Eugenia Trushina, T.K.O. Nguyen, S. Trushin

    Riassunto Riassunto Mappa Mappa  
  • ·Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies

    Pagina :686-698

    M. Kiraly, J.F. Foss, Tony Giordano

    Riassunto Riassunto Mappa Mappa  
  • ·Targeting Endogenous Mechanisms of Brain Resilience for the Treatment and Prevention of Alzheimer’s Disease

    Pagina :699-705

    H.R.C. Shanks, K.M. Onuska, S.M. Massa, Taylor W. Schmitz, Frank M. Longo

    Riassunto Riassunto Mappa Mappa  
  • ·Metformin in the Prevention of Alzheimer’s Disease and Alzheimer’s Disease Related Dementias

    Pagina :706-717

    M. Tahmi, José A. Luchsinger

    Riassunto Riassunto Mappa Mappa  
  • ·Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease

    Pagina :718-728

    M. Barbera, D. Perera, A. Matton, F. Mangialasche, A. Rosenberg, L. Middleton, T. Ngandu, A. Solomon, Miia Kivipelto

    Riassunto Riassunto Mappa Mappa  
  • ·The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging

    Pagina :729-742

    M. Owen, N. Bose, L. Nisenbaum, K.A. Partrick, Howard M. Fillit

    Riassunto Riassunto Mappa Mappa

• Commentary

  • ·Future of Alzheimer’s Disease Treatment: Combination Therapy and Precision Medicine

    Pagina :743-745

    Howard M. Fillit, L.K. Nisenbaum, A.H. Burstein

    

• Editorial

  • ·Dietary Cholesterol and Dementia Risk

    Pagina :746-747

    Lefkos T. Middleton, E. Riboli

    

• Original Research

  • ·High Intake of Dietary Cholesterol Decreases the Risk of All-Cause Dementia and AD Dementia: A Results from Framingham Offspring Cohort

    Pagina :748-755

    Mingmin Wang, Yanqiu Wang, Y. Zhang, W. Zhang, Y. Wang, R. Fan, Yi Wen

    Riassunto Riassunto Mappa Mappa   
  • ·Preferences about Future Alzheimer’s Disease Treatments Elicited through an Online Survey Using the Threshold Technique

    Pagina :756-764

    Sonia Roldan Munoz, S.T. de Vries, G. Lankester, F. Pignatti, B.C. van Munster, I. Radford, L. Guizzaro, P.G.M. Mol, H. Hillege, D. Postmus

    Riassunto Riassunto Mappa Mappa   

• Brief Communication

  • ·Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval

    Pagina :765-770

    Matthew D. Howe, K.J. Britton, H.E. Joyce, G.J. Pappas, M.A. Faust, B.C. Dawson, M.C. Riddle, S.P. Salloway

    Riassunto Riassunto Mappa Mappa   

• Original Research

  • ·Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer’s Disease

    Pagina :771-777

    Sharon Cohen, C.H. van Dyck, M. Gee, T. Doherty, M. Kanekiyo, S. Dhadda, D. Li, S. Hersch, M. Irizarry, L.D. Kramer

    Riassunto Riassunto Mappa Mappa   
  • ·Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects

    Pagina :778-789

    K. Önnestam, B. Nilsson, M. Rother, E. Rein-Hedin, J. Bylund, P. Anderer, M. Kemethofer, M.M. Halldin, J. Sandin, Märta Segerdahl

    Riassunto Riassunto Mappa Mappa   
  • ·A Randomized Prospective Survey Targeting Knowledge, Barriers, Facilitators and Readiness to Participation in Dementia Research

    Pagina :790-799

    Martha Sajatovic, L.K. Herrmann, C. Knebusch, K. Sarna, A.J. Lerner, E. Fuentes-Casiano, C.J. Burant

    Riassunto Riassunto Mappa Mappa  
  • ·Protocol of a Phase II Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial of S-Adenosyl Methionine in Participants with Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease

    Pagina :800-809

    Sarah Holper, R. Watson, L. Churilov, P. Yates, Y.Y. Lim, K.J. Barnham, N. Yassi

    Riassunto Riassunto Mappa Mappa   
  • ·Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia

    Pagina :810-820

    Hussein Yassine, I.C. Arellanes, A. Mazmanian, L. De La Cruz, J. Martinez, L. Contreras, N. Kono, B.S. Liu, D. Badie, M.A. Bantugan, A. Grindon, T. Urich, L. D’Orazio, B.A. Emmanuel, H.C. Chui, W.J. Mack, M.G. Harrington, M.N. Braskie, L.S. Schneider

    Riassunto Riassunto Mappa Mappa   
  • ·Reducing the Effects of Ageing on Cognition with Therapeutic Intervention of an Oral Multi-Nutrient: The REACTION Pilot Trial Study Design

    Pagina :821-827

    Christian J. Camargo, S. Merritt, M. Modjeski, D.S. Counotte, K. Fernández McInerney

    Riassunto Riassunto Mappa Mappa  
  • ·Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum

    Pagina :828-836

    A. Feizpour, V. Doré, J.D. Doecke, Z.S. Saad, G. Triana-Baltzer, R. Slemmon, P. Maruff, N. Krishnadas, P. Bourgeat, K. Huang, C. Fowler, S.R. Rainey-Smith, A.I. Bush, L. Ward, J. Robertson, R.N. Martins, C.L. Masters, V.L. Villemagne, J. Fripp, H.C. Kolb, Christopher C. Rowe

    Riassunto Riassunto Mappa Mappa   
  • ·Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition

    Pagina :837-846

    S.-M. Wang, D.W. Kang, Y.H. Um, S.-H. Kim, C.U. Lee, P. Scheltens, Hyun Kook Lim

    Riassunto Riassunto Mappa Mappa  
  • ·The Community Engaged Digital Alzheimer’s Research (CEDAR) Study: A Digital Intervention to Increase Research Participation of Black American Participants in the Brain Health Registry

    Pagina :847-856

    M.R. Mindt, M.T. Ashford, D. Zhu, H. Cham, A. Aaronson, C. Conti, X. Deng, R. Alaniz, J. Sorce, C. Cypress, P. Griffin, D. Flenniken, M. Camacho, J. Fockler, D. Truran, R.S. Mackin, C. Hill, M.W. Weiner, D. Byrd, R.W. Turner, Rachel L. Nosheny

    Riassunto Riassunto Mappa Mappa  
  • ·Development of a Mobile-First Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer’s Disease Prevention Studies

    Pagina :857-864

    R. Aggarwal, E. Sidnam-Mauch, D. Neffa-Creech, A. Plant, E. Williams, E. Shami, U. Menon, S. George, Jessica Langbaum

    Riassunto Riassunto Mappa Mappa  
  • ·Understanding Barriers and Facilitators to Signing Up for a Mobile-Responsive Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer’s Disease Prevention Studies

    Pagina :865-874

    D. Neffa-Creech, R. Aggarwal, C. Stowell, U. Menon, S. George, A. Plant, Jessica Langbaum

    Riassunto Riassunto Mappa Mappa
  • ·Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A Prospective 12-Month Intervention Study

    Pagina :875-885

    Howard H. Feldman, S. Belleville, H.B. Nygaard, M. Montero-Odasso, J. Durant, J.-L. Lupo, C. Revta, S. Chan, M. Cuesta, P.J. Slack, S. Winer, P.W.H. Brewster, S.M. Hofer, A. Lim, A. Centen, D.M. Jacobs, N.D. Anderson, J.D. Walker, M.R. Speechley, G.Y. Zou, H. Chertkow, Canadian Consortium on Neurodegeneration in Aging (CCNA), CAN-THUMBS UP Study Group

    Riassunto Riassunto Mappa Mappa   
  • ·Genotypic Effects of the TOMM40’523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study

    Pagina :886-894

    H. Zou, Sheng Luo, H. Liu, M.W. Lutz, D.A. Bennett, B.L. Plassman, K.A. Welsh-Bohmer

    Riassunto Riassunto Mappa Mappa   
  • ·Social Determinants of Health among Older Adults with Dementia in Urban and Rural Areas

    Pagina :895-902

    Mairead M. Bartley, H. Baer-Benson, D.R. Schroeder, J.L. St. Sauver, N. Khera, J.M. Griffin

    Riassunto Riassunto Mappa Mappa  
  • ·Association of Loneliness with Cognitive Functions

    Pagina :903-908

    Kay Thwe Kyaw, A. Levine

    Riassunto Riassunto Mappa Mappa